U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Adenoid Cystic Carcinoma

MedGen UID:
1674191
•Concept ID:
C4763763
•
Neoplastic Process

Definition

The reemergence of adenoid cystic carcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Adenoid Cystic Carcinoma

Professional guidelines

PubMed

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG
Lancet Oncol 2011 Aug;12(8):815-24. Epub 2010 Dec 10 doi: 10.1016/S1470-2045(10)70245-X. PMID: 21147032
Management of malignant tracheobronchial stenoses with the use of airway stents.
Su JM, Wu TC, Wu MF, Chang H, Chou MC
J Chin Med Assoc 2004 Sep;67(9):458-64. PMID: 15617306
Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy.
Douglas JG, Laramore GE, Austin-Seymour M, Koh W, Stelzer K, Griffin TW
Int J Radiat Oncol Biol Phys 2000 Feb 1;46(3):551-7. doi: 10.1016/s0360-3016(99)00445-9. PMID: 10701733

Recent clinical studies

Etiology

Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
Fukuda N, Fujiwara Y, Wang X, Ohmoto A, Urasaki T, Hayashi N, Sato Y, Nakano K, Yunokawa M, Ono M, Tomomatsu J, Takahashi S
Eur Arch Otorhinolaryngol 2021 Aug;278(8):3037-3043. Epub 2020 Nov 21 doi: 10.1007/s00405-020-06481-y. PMID: 33219858
A case-cohort study of recurrent salivary adenoid cystic carcinoma after iodine 125 brachytherapy and resection treatment.
Li BB, Xie XY, Jia SN
Ann Diagn Pathol 2015 Feb;19(1):1-5. Epub 2014 Nov 28 doi: 10.1016/j.anndiagpath.2014.11.001. PMID: 25496646
Role of radiotherapy in adenoid cystic carcinoma of the head and neck.
Iseli TA, Karnell LH, Graham SM, Funk GF, Buatti JM, Gupta AK, Robinson RA, Hoffman HT
J Laryngol Otol 2009 Oct;123(10):1137-44. Epub 2009 Jul 2 doi: 10.1017/S0022215109990338. PMID: 19573256
The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma.
Papadaki H, Finkelstein SD, Kounelis S, Bakker A, Swalsky PA, Kapadia SB
Hum Pathol 1996 Jun;27(6):567-72. doi: 10.1016/s0046-8177(96)90163-x. PMID: 8666366
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group.
Vermorken JB, Verweij J, de Mulder PH, Cognetti F, Clavel M, Rodenhuis S, Kirkpatrick A, Snow GB
Ann Oncol 1993 Nov;4(9):785-8. doi: 10.1093/oxfordjournals.annonc.a058665. PMID: 8280659

Diagnosis

A Case of Neglected, Recurrent Adenoid Cystic Carcinoma of Parotid Gland.
Low A, Kadir AJ, Wong KT, Choo MM
Ophthalmic Plast Reconstr Surg 2021 Sep-Oct 01;37(5):e193. doi: 10.1097/IOP.0000000000001947. PMID: 33795606
(18) F-FDG PET/MRI vs MRI in patients with recurrent adenoid cystic carcinoma.
Kirchner J, Schaarschmidt BM, Sauerwein W, Deuschl C, Arweiler-Harbeck D, Holtmann L, Stebner V, Umutlu L, Antoch G, Ruhlmann V
Head Neck 2019 Jan;41(1):170-176. Epub 2018 Dec 13 doi: 10.1002/hed.25485. PMID: 30548894
Detection of atypical metastases in recurrent adenoid cystic carcinoma of parotid gland.
Tewari A, Padma S, Sundaram PS
J Cancer Res Ther 2013 Jan-Mar;9(1):148-50. doi: 10.4103/0973-1482.110374. PMID: 23575100
Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group.
Verweij J, de Mulder PH, de Graeff A, Vermorken JB, Wildiers J, Kerger J, Schornagel J, Cognetti F, Kirkpatrick A, Sahmoud T, Lefebvre JL
Ann Oncol 1996 Oct;7(8):867-9. doi: 10.1093/oxfordjournals.annonc.a010770. PMID: 8922205
Recurrent adenoid cystic carcinoma of the trachea: intraluminal radiotherapy.
Price JC, Percarpio B, Murphy PW, Henderson RL
Otolaryngol Head Neck Surg (1979) 1979 Sep-Oct;87(5):614-23. doi: 10.1177/019459987908700514. PMID: 228226

Therapy

Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
Fukuda N, Fujiwara Y, Wang X, Ohmoto A, Urasaki T, Hayashi N, Sato Y, Nakano K, Yunokawa M, Ono M, Tomomatsu J, Takahashi S
Eur Arch Otorhinolaryngol 2021 Aug;278(8):3037-3043. Epub 2020 Nov 21 doi: 10.1007/s00405-020-06481-y. PMID: 33219858
A case-cohort study of recurrent salivary adenoid cystic carcinoma after iodine 125 brachytherapy and resection treatment.
Li BB, Xie XY, Jia SN
Ann Diagn Pathol 2015 Feb;19(1):1-5. Epub 2014 Nov 28 doi: 10.1016/j.anndiagpath.2014.11.001. PMID: 25496646
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG
Lancet Oncol 2011 Aug;12(8):815-24. Epub 2010 Dec 10 doi: 10.1016/S1470-2045(10)70245-X. PMID: 21147032
Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy.
Douglas JG, Laramore GE, Austin-Seymour M, Koh W, Stelzer K, Griffin TW
Int J Radiat Oncol Biol Phys 2000 Feb 1;46(3):551-7. doi: 10.1016/s0360-3016(99)00445-9. PMID: 10701733
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group.
Vermorken JB, Verweij J, de Mulder PH, Cognetti F, Clavel M, Rodenhuis S, Kirkpatrick A, Snow GB
Ann Oncol 1993 Nov;4(9):785-8. doi: 10.1093/oxfordjournals.annonc.a058665. PMID: 8280659

Prognosis

Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
Fukuda N, Fujiwara Y, Wang X, Ohmoto A, Urasaki T, Hayashi N, Sato Y, Nakano K, Yunokawa M, Ono M, Tomomatsu J, Takahashi S
Eur Arch Otorhinolaryngol 2021 Aug;278(8):3037-3043. Epub 2020 Nov 21 doi: 10.1007/s00405-020-06481-y. PMID: 33219858
Successful management of recurrent adenoid cystic carcinoma in the deep infratemporal fossa by maxillo-orbito-zygomatic approach.
Hongo T, Fukushima J, Uchida Y, Rikimaru F, Toh S, Higaki Y, Masuda M
Auris Nasus Larynx 2019 Dec;46(6):921-926. Epub 2019 Jan 6 doi: 10.1016/j.anl.2018.12.010. PMID: 30626547
(18) F-FDG PET/MRI vs MRI in patients with recurrent adenoid cystic carcinoma.
Kirchner J, Schaarschmidt BM, Sauerwein W, Deuschl C, Arweiler-Harbeck D, Holtmann L, Stebner V, Umutlu L, Antoch G, Ruhlmann V
Head Neck 2019 Jan;41(1):170-176. Epub 2018 Dec 13 doi: 10.1002/hed.25485. PMID: 30548894
A case-cohort study of recurrent salivary adenoid cystic carcinoma after iodine 125 brachytherapy and resection treatment.
Li BB, Xie XY, Jia SN
Ann Diagn Pathol 2015 Feb;19(1):1-5. Epub 2014 Nov 28 doi: 10.1016/j.anndiagpath.2014.11.001. PMID: 25496646
Role of radiotherapy in adenoid cystic carcinoma of the head and neck.
Iseli TA, Karnell LH, Graham SM, Funk GF, Buatti JM, Gupta AK, Robinson RA, Hoffman HT
J Laryngol Otol 2009 Oct;123(10):1137-44. Epub 2009 Jul 2 doi: 10.1017/S0022215109990338. PMID: 19573256

Clinical prediction guides

(18) F-FDG PET/MRI vs MRI in patients with recurrent adenoid cystic carcinoma.
Kirchner J, Schaarschmidt BM, Sauerwein W, Deuschl C, Arweiler-Harbeck D, Holtmann L, Stebner V, Umutlu L, Antoch G, Ruhlmann V
Head Neck 2019 Jan;41(1):170-176. Epub 2018 Dec 13 doi: 10.1002/hed.25485. PMID: 30548894
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG
Lancet Oncol 2011 Aug;12(8):815-24. Epub 2010 Dec 10 doi: 10.1016/S1470-2045(10)70245-X. PMID: 21147032
Role of radiotherapy in adenoid cystic carcinoma of the head and neck.
Iseli TA, Karnell LH, Graham SM, Funk GF, Buatti JM, Gupta AK, Robinson RA, Hoffman HT
J Laryngol Otol 2009 Oct;123(10):1137-44. Epub 2009 Jul 2 doi: 10.1017/S0022215109990338. PMID: 19573256
Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy.
Douglas JG, Laramore GE, Austin-Seymour M, Koh W, Stelzer K, Griffin TW
Int J Radiat Oncol Biol Phys 2000 Feb 1;46(3):551-7. doi: 10.1016/s0360-3016(99)00445-9. PMID: 10701733
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group.
Vermorken JB, Verweij J, de Mulder PH, Cognetti F, Clavel M, Rodenhuis S, Kirkpatrick A, Snow GB
Ann Oncol 1993 Nov;4(9):785-8. doi: 10.1093/oxfordjournals.annonc.a058665. PMID: 8280659

Recent systematic reviews

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG
Lancet Oncol 2011 Aug;12(8):815-24. Epub 2010 Dec 10 doi: 10.1016/S1470-2045(10)70245-X. PMID: 21147032

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...